We are live on ! Find out more
MG

Michael Gelband ExodusPoint Capital Management

AUM $15.5B
1-Year Est. Return 38.81%
 

Michael Gelband is a co-founder of ExodusPoint Capital Management, a multi-strategy hedge fund launched by veterans of larger alternative platforms. The firm pursues diversified strategies across asset classes with a focus on risk-managed absolute returns. Gelband’s firm is followed as part of the newer generation of multi-strategy complexes.

This Fund
S&P 500
This Quarter Est. Return
+13.04%
1 Year Est. Return
+38.81%
3 Year Est. Return
+110.53%
5 Year Est. Return
+124.16%
10 Year Est. Return
AUM
$6.86B
AUM Growth
-$3.41B
Cap. Flow
-$3.78B
Cap. Flow %
-55.19%
Top 10 Hldgs %
25.96%
Holding
2,871
New
973
Increased
552
Reduced
524
Closed
811

Top Sells

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$378M
2
AMZN icon
Amazon
AMZN
+$336M
3
AAPL icon
Apple
AAPL
+$294M
4
BABA icon
Alibaba
BABA
+$258M
5
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$136M

Sector Composition

Rank Sector Weight
1 Technology 12.92%
2 Consumer Discretionary 8.02%
3 Utilities 7.46%
4 Healthcare 7.42%
5 Financials 7.39%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SRE icon
2576
Sempra
SRE
$54.2B
-272,764
Closed -$17.4M
SSL icon
2577
Sasol
SSL
$8.01B
-12,371
Closed -$110K
SSTK icon
2578
Shutterstock
SSTK
$197M
-8,151
Closed -$584K
STAA icon
2579
CALL
STAAR Surgical
STAA
$1.16B
-20,000
Closed -$1.58M
STE icon
2580
Steris
STE
$23.2B
-2,980
Closed -$565K
STEP icon
2581
StepStone Group
STEP
$4.11B
-7,121
Closed -$283K
STM icon
2582
STMicroelectronics
STM
$45.1B
-12,966
Closed -$481K
STOK icon
2583
Stoke Therapeutics
STOK
$2.08B
-4,944
Closed -$306K
STX icon
2584
Seagate
STX
$193B
-18,794
Closed -$1.17M
STWD icon
2585
Starwood Property Trust
STWD
$6.06B
-65,755
Closed -$1.27M
SVC
2586
Service Properties Trust
SVC
$1.05B
-4,984
Closed -$286K
SWTX
2587
DELISTED
SpringWorks Therapeutics
SWTX
-3,634
Closed -$264K
SXI icon
2588
Standex International
SXI
$3.76B
-4,374
Closed -$339K
T icon
2589
AT&T
T
$173B
-828,803
Closed -$18M
TAN icon
2590
Invesco Solar ETF
TAN
$1.29B
-18,500
Closed -$1.9M
TBI
2591
Trueblue
TBI
$323M
-30,541
Closed -$571K
TCPC icon
2592
BlackRock TCP Capital
TCPC
$338M
-38,714
Closed -$435K
TCRT icon
2593
Alaunos Therapeutics
TCRT
$4.47M
-139
Closed -$53K
TDOC icon
2594
Teladoc Health
TDOC
$1.16B
-3,053
Closed -$610K
TDY icon
2595
Teledyne Technologies
TDY
$29.5B
-2,396
Closed -$939K
TEF
2596
DELISTED
Telefonica
TEF
-53,786
Closed -$193K
TGI
2597
DELISTED
Triumph Group
TGI
-59,424
Closed -$746K
TGNA
2598
DELISTED
TEGNA Inc
TGNA
-23,822
Closed -$332K
THO icon
2599
Thor Industries
THO
$4.14B
-9,018
Closed -$839K
THS
2600
DELISTED
Treehouse Foods
THS
-21,912
Closed -$931K

Similar funds

Michael Gelband's Q1 2021 Portfolio in Review

As of Q1 2021, Michael Gelband held 2,871 positions worth $6.86B, down 33% from $10.3B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Michael Gelband withdrew a net $3.78B in Q1 2021, closing 811 positions and reducing 524 holdings. Its most notable exit was Alibaba, an estimated $258M position sold in full.

By sector, the portfolio is most concentrated in Technology at 13% of assets, down from 14% a quarter earlier, followed by Consumer Discretionary and Utilities.

Against the trend, Michael Gelband opened a new position in Comcast worth $39.1M.

  • Michael Gelband's largest Q1 2021 buy was Comcast: 722,523 shares worth $39.1M.
  • Michael Gelband added most to iShares Russell 1000 Value ETF in Q1 2021, an estimated $48M increase.
  • Michael Gelband's biggest Q1 2021 reduction was Microsoft, cutting an estimated $378M.
  • Michael Gelband fully exited Alibaba in Q1 2021, selling an estimated $258M.
  • Michael Gelband's ten largest holdings make up 26% of its $6.86B portfolio in Q1 2021.
  • Michael Gelband opened 973 new positions and closed 811 in Q1 2021.
  • Michael Gelband's portfolio value fell 33% quarter-over-quarter to $6.86B.

Based on ExodusPoint Capital Management's 13F filing for Q1 2021, filed 17 May 2021.